Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

AUTOR(ES)

Huang, Ngan F.

FONTE

MyJove Corporation

RESUMO

Peripheral arterial disease (PAD) results from narrowing of the peripheral arteries that supply oxygenated blood and nutrients to the legs and feet, This pathology causes symptoms such as intermittent claudication (pain with walking), painful ischemic ulcerations, or even limb-threatening gangrene. It is generally believed that the vascular endothelium, a monolayer of endothelial cells that invests the luminal surface of all blood and lymphatic vessels, plays a dominant role in vascular homeostasis and vascular regeneration. As a result, stem cell-based regeneration of the endothelium may be a promising approach for treating PAD.

Documentos Relacionados

• Instructing an Embryonic Stem Cell-Derived Oocyte Fate: Lessons from Endogenous Oogenesis
• MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes
• Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors
• Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice
• Long-term reconstitution of the mouse hematopoietic system by embryonic stem cell-derived fetal liver.